General Info
Xavier Duportet, 29, is a genome architect. He cofounded Eligo Bioscience in 2014, while doing his PhD in Synthetic Biology at MIT and INRIA…
Location: Paris
Country:
Industries:
Investment Regions: EU
Investment Stages: late-stage, pre-seed, seed, series-a
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Found evidence that Xavier Duportet was CEO/co-founder of Eligo Bioscience and that Eligo raised $30M in a Series B on December 5, 2023, with quotes from Xavier Duportet. The last known investment activity (company funding) is December 5, 2023. Calculating from that date to the reference date yields that the last activity occurred more than 12 months ago (~22 months prior), so classify as not-active. Startup invested: Eligo Bioscience.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Xavier Duportet
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI